This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Taddei, S. Articles by Salvetti, A. Search for Related Content PubMed PubMed Citation Articles by Taddei, S. Articles by Salvetti, A.

Circulation, Vol 82, 2061-2067, Copyright © 1990 by American Heart Association

ARTICLES

Sympathetic nervous system-dependent vasoconstriction in humans. Evidence for mechanistic role of endogenous purine compounds

S Taddei, R Pedrinelli and A Salvetti
I Clinica Medica, University of Pisa, Italy.

Purine compounds modulate sympathetic neurotransmission; this modulation decreases nervous discharge by stimulating presynaptic inhibitory adenosine receptors, an effect antagonized by theophylline, and causes vasoconstriction through the stimulation of postsynaptic ATP receptors. In humans we evaluated the effect of local theophylline, which was infused into the brachial artery at the rate of 100 micrograms/100 cc/min, on the arteriolar sympathetic vasoconstriction induced by applying a lower-body negative pressure. Forearm blood flow changes were measured by strain-gauge venous plethysmography. Theophylline, which at this dosage blunted the vasodilator effect of adenosine (the physiological agonist for the P1 purinoceptor), significantly increased lower-body negative pressure-mediated vasoconstriction. To evaluate whether neurotransmitters different from norepinephrine participate in the vasoconstrictor effect of theophylline, we repeated the previous experiment in the presence of phenoxybenzamine, which was infused at a dose (60 micrograms/100 cc/min) that abolished the vasoconstrictor effect of norepinephrine. Also, after alpha-adrenoceptor blockade, theophylline continued to increase sympathetic vasoconstriction. Our data confirm that purinergic receptors and neurotransmitters also participate in endogenous sympathetic vasoconstriction in humans.

This article has been cited by other articles:

				D. L. Kellogg Jr In vivo mechanisms of cutaneous vasodilation and vasoconstriction in humans during thermoregulatory challenges J Appl Physiol, May 1, 2006; 100(5): 1709 - 1718. [Abstract] [Full Text] [PDF]

				J. M. Johnson, T. C. Yen, K. Zhao, and W. A. Kosiba Sympathetic, sensory, and nonneuronal contributions to the cutaneous vasoconstrictor response to local cooling Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1573 - H1579. [Abstract] [Full Text] [PDF]

				D. P. Stephens, A. R. Saad, L. A. T. Bennett, W. A. Kosiba, and J. M. Johnson Neuropeptide Y antagonism reduces reflex cutaneous vasoconstriction in humans Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1404 - H1409. [Abstract] [Full Text] [PDF]

				C. S. Thompson and W. L. Kenney Altered neurotransmitter control of reflex vasoconstriction in aged human skin J. Physiol., July 15, 2004; 558(2): 697 - 704. [Abstract] [Full Text] [PDF]

				M. E. J. Lott, C. S. Hogeman, L. Vickery, A. R. Kunselman, L. I. Sinoway, and D. A. MacLean Effects of dynamic exercise on mean blood velocity and muscle interstitial metabolite responses in humans Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1734 - H1741. [Abstract] [Full Text] [PDF]

				D. P. Stephens, K. Aoki, W. A. Kosiba, and J. M. Johnson Nonnoradrenergic mechanism of reflex cutaneous vasoconstriction in men Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1496 - H1504. [Abstract] [Full Text] [PDF]

				G. A. Rongen, J. W.M. Lenders, J. Lambrou, J. J. Willemsen, H. Van Belle, T. Thien, and P. Smits Presynaptic Inhibition of Norepinephrine Release From Sympathetic Nerve Endings by Endogenous Adenosine Hypertension, April 1, 1996; 27(4): 933 - 938. [Abstract] [Full Text]